Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
BBC vs PILL
Shared holdings
18
BBC covered by PILL
17.01%
PILL covered by BBC
17.01%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
BBC (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 2.23% | |
| ERASCA INC | 2.14% | |
| ENLIVEN THERAPEUTICS INC | 1.77% | |
| TANGO THERAPEUTICS INC | 1.67% | |
| ORUKA THERAPEUTICS INC | 1.64% | |
| SPYRE THERAPEUTICS INC | 1.60% | |
| ALUMIS INC | 1.55% | |
| DIANTHUS THERAPEUTICS INC | 1.51% | |
| KODIAK SCIENCES INC | 1.32% | |
| REVOLUTION MEDICINES INC | 1.32% | |
| CORVUS PHARMACEUTICALS INC | 1.31% | |
| REZOLUTE INC | 1.29% | |
| DEFINIUM THERAPEUTICS INC | 1.26% | |
| CG ONCOLOGY INC | 1.18% | |
| JADE BIOSCIENCES INC | 1.18% | |
| INHIBRX BIOSCIENCES INC | 1.17% | |
| RELAY THERAPEUTICS INC | 1.17% | |
| GH RESEARCH PLC | 1.14% | |
| NEKTAR THERAPEUTICS | 1.12% | |
| TYRA BIOSCIENCES INC | 1.11% | |
| VIR BIOTECHNOLOGY INC | 1.10% | |
| INTELLIA THERAPEUTICS INC | 1.08% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.08% | |
| ANAPTYSBIO INC | 1.06% | |
| OMEROS CORP | 1.04% | |
| TECTONIC THERAPEUTIC INC | 1.02% | |
| ALLOGENE THERAPEUTICS INC | 1.02% | |
| COMPASS Pathways PLC, ADR | 0.97% | |
| EDGEWISE THERAPEUTICS INC | 0.95% | |
| PALVELLA THERAPEUTICS INC | 0.94% | |
| CAPRICOR THERAPEUTICS INC | 0.93% | |
| VAXCYTE INC | 0.93% | |
| PHARVARIS NV | 0.93% | |
| ARRIVENT BIOPHARMA INC | 0.92% | |
| XENON PHARMACEUTICALS INC | 0.92% | |
| NEUROGENE INC | 0.90% | |
| SUMMIT THERAPEUTICS INC | 0.88% | |
| AMYLYX PHARMACEUTICALS INC | 0.88% | |
| CELLDEX THERAPEUTICS INC | 0.86% | |
| PRAXIS PRECISION MEDICINES INC | 0.86% | |
| ARCUS BIOSCIENCES INC | 0.86% | |
| ANNEXON INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.85% | |
| LIQUIDIA TECHNOLOGIES INC | 0.85% | |
| MONTE ROSA THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| BICARA THERAPEUTICS INC | 0.84% | |
| CELCUITY INC | 0.83% | |
| IRONWOOD PHARMA CL A (PEND) | 0.83% | |
| AbCellera Biologics Inc COM | 0.83% |
PILL (April 30, 2026)
| Security | Weight | |
|---|---|---|
| GOLDMAN FINL SQ TRSRY INST 506 | 18.36% | |
| US ULTRA BOND CBT Sep25 | 6.01% | |
| DREYFUS GOVT CASH MGMT FUND | 3.62% | |
| ORGANON & CO | 2.68% | |
| CORCEPT THERAPEUTICS INC | 1.78% | |
| ENLIVEN THERAPEUTICS INC | 1.74% | |
| AXSOME THERAPEUTICS INC | 1.68% | |
| OMEROS CORP | 1.58% | |
| PERRIGO CO PLC | 1.56% | |
| DEFINIUM THERAPEUTICS INC | 1.52% | |
| NEKTAR THERAPEUTICS | 1.50% | |
| TREVI THERAPEUTICS INC | 1.49% | |
| TERNS PHARMACEUTICALS INC | 1.46% | |
| INDIVIOR PHARMACEUTICALS INC | 1.45% | |
| PACIRA BIOSCIENCES INC | 1.44% | |
| HARROW INC | 1.42% | |
| JAZZ PHARMACEUTI | 1.42% | |
| HARMONY BIOSCIENCES HOLDINGS INC | 1.40% | |
| ROYALTY PHARMA-A | 1.39% | |
| AMYLYX PHARMACEUTICALS INC | 1.39% | |
| VIATRIS INC | 1.38% | |
| CRINETICS PHARMACEUTICALS INC | 1.36% | |
| ANI PHARMACEUTICALS INC | 1.35% | |
| LIGAND PHARMACEUTICALS | 1.34% | |
| MBX BIOSCIENCES INC | 1.33% | |
| INNOVIVA INC | 1.33% | |
| LIQUIDIA TECHNOLOGIES INC | 1.32% | |
| AMNEAL PHARM INC | 1.31% | |
| XERIS BIOPHARMA HOLDINGS INC | 1.31% | |
| BRISTOL-MYERS SQUIBB CO | 1.31% | |
| EDGEWISE THERAPEUTICS INC | 1.29% | |
| OCULAR THERAPEUTIX INC | 1.28% | |
| PFIZER INC | 1.27% | |
| NUVATION BIO INC | 1.25% | |
| ZOETIS INC CL A | 1.24% | |
| ELANCO ANIMAL HEALTH INC | 1.23% | |
| COLLEGIUM PHARMACEUTICAL INC | 1.23% | |
| JOHNSON&JOHNSON | 1.22% | |
| MERCK & CO | 1.22% | |
| ALUMIS INC | 1.21% | |
| LILLY ELI and CO | 1.21% | |
| TARSUS PHARMACEUTICALS INC | 1.18% | |
| SUPERNUS PHARMACEUTICALS INC | 1.17% | |
| PHIBRO ANIMAL HEALTH CORP CL A | 1.16% | |
| EYEPOINT PHARMACEUTICALS INC | 1.14% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 1.12% | |
| AMPHASTAR PHARMACEUTICALS INC | 1.10% | |
| THERAVANCE B | 0.99% | |
| PHATHOM PHARMACEUTICALS INC | 0.98% | |
| RAPPORT THERAPEUTICS INC | 0.98% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.